The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.

J Astemborski, D Vlahov, D Warren, L Solomon, K E Nelson
Author Information
  1. J Astemborski: Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.

Abstract

OBJECTIVES: Data from 538 women in a cohort study recruited in 1988-1989 were analyzed to determined whether trading sex for drugs or money was independently associated with human immunodeficiency virus (HIV) seroprevalence in a population of female intravenous drug users.
METHODS: The women were grouped according to the number of partners with whom they reported trading sex for drugs or money during the previous 10 years: none, 1 through 49 (low), or 50 or more (high); the prevalence of HIV seropositivity in the three groups was 23.2%, 23.7%, and 47.6%, respectively. Logistic regression was used to compare the low- and high-trade groups separately with the group that reported no trading.
RESULTS: Low trading was not associated with seroprevalent HIV infection. In a multivariate model, high trading (compared with no trading) was significantly associated with HIV seropositivity after adjustment for cocaine use, history of sexually transmitted diseases, and duration of intravenous drug use.
CONCLUSIONS: These data indicate that, among intravenous drug-using women, high levels of trading sex for drugs or money were independently associated with HIV infection. This group needs to be targeted for further intensive intervention.

References

  1. JAMA. 1986 May 2;255(17):2289 [PMID: 3754290]
  2. Br J Addict. 1992 Mar;87(3):417-28 [PMID: 1559040]
  3. N Engl J Med. 1987 Oct 29;317(18):1125-35 [PMID: 3309656]
  4. AIDS. 1987 May;1(1):39-44 [PMID: 3122788]
  5. AIDS. 1988 Feb;2(1):55-60 [PMID: 3128998]
  6. Int J Epidemiol. 1988 Mar;17(1):162-7 [PMID: 3260223]
  7. JAMA. 1989 Jan 27;261(4):561-5 [PMID: 2909798]
  8. Genitourin Med. 1989 Jun;65(3):146-50 [PMID: 2788121]
  9. N Engl J Med. 1989 Sep 28;321(13):874-9 [PMID: 2770823]
  10. J Acquir Immune Defic Syndr. 1990;3(2):192-3 [PMID: 2295978]
  11. J Infect Dis. 1990 Nov;162(5):1007-11 [PMID: 2230228]
  12. Am J Epidemiol. 1990 Nov;132(5):847-56 [PMID: 2239899]
  13. J Acquir Immune Defic Syndr. 1991;4(6):607-13 [PMID: 2023101]
  14. AIDS. 1991 Jan;5(1):77-83 [PMID: 2059364]
  15. J Infect Dis. 1991 Sep;164(3):457-63 [PMID: 1869836]
  16. J Acquir Immune Defic Syndr. 1991;4(10):938-44 [PMID: 1890603]
  17. Am J Drug Alcohol Abuse. 1991 Sep;17(3):337-53 [PMID: 1928027]
  18. AIDS. 1991 Sep;5(9):1121-6 [PMID: 1930775]
  19. Am J Epidemiol. 1991 Nov 15;134(10):1175-89 [PMID: 1746528]
  20. Am J Public Health. 1991 Dec;81(12):1576-9 [PMID: 1746652]
  21. Am J Epidemiol. 1992 Feb 1;135(3):225-33 [PMID: 1312300]
  22. Am J Public Health. 1987 Feb;77(2):169-72 [PMID: 3467596]

Grants

  1. DA 04334/NIDA NIH HHS
  2. DA 05911/NIDA NIH HHS

MeSH Term

Adult
Cohort Studies
Female
HIV Seropositivity
Humans
Odds Ratio
Prevalence
Risk Factors
Sex Work
Sexual Behavior
Sexual Partners
Substance Abuse, Intravenous

Word Cloud

Created with Highcharts 10.0.0tradingHIVsexdrugsmoneyassociatedintravenouswomendrughighseropositivityindependentlyfemaleusersreportedgroups23groupinfectionuseamongOBJECTIVES:Data538cohortstudyrecruited1988-1989analyzeddeterminedwhetherhumanimmunodeficiencyvirusseroprevalencepopulationMETHODS:groupedaccordingnumberpartnersprevious10years:none149low50prevalencethree2%7%476%respectivelyLogisticregressionusedcomparelow-high-tradeseparatelyRESULTS:LowseroprevalentmultivariatemodelcomparedsignificantlyadjustmentcocainehistorysexuallytransmitteddiseasesdurationCONCLUSIONS:dataindicatedrug-usinglevelsneedstargetedintensiveintervention

Similar Articles

Cited By